U.S. drug companies reach settlement ahead of landmark opioids trial

  • 📰 rapplerdotcom
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 86%

United States News News

United States United States Latest News,United States United States Headlines

Three leading drug distributors and an Israeli drugmaker blamed for a deadly US opioid epidemic settled with plaintiffs Monday, October 21, just hours before they were to go on trial.

The settlement involved the 3 leading US drug distributors – Cardinal Health, Amerisource Bergen, and McKesson Corp and Israel's generic drug manufacturer Teva.

Although the deal involved only Cuyahoba and Summit counties of Ohio, it stands as a possible a bellwether for states, cities, counties and Native American communities around the country. Johnson & Johnson had previously broken away with its own settlement, a $20.4 million deal with the two Ohio counties, which encompass the cities of Cleveland and Akron.

But the parties could not come to an agreement on a proposed settlement valued at $48 billion, including $18 billion in cash, after meetings on Friday.But other states and many smaller litigants were dissatisfied with the amount, the size of the cash component, lawyers' fees and the way the money would be distributed.

The Society of Actuaries report projects that for this year alone the cost could be $172-214 billion.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 4. in US

United States United States Latest News, United States United States Headlines